Clinical trial
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis
NCT05540457 is registered in ClinicalTrials.gov with The Rogosin Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis
- Lead sponsor
- The Rogosin Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 22, 2022
- Completion date
- February 9, 2024
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dialysis hypotension, dialysis induced hypertension, end stage renal disease, end stage renal disease on dialysis